President Donald Trump, speaking in the White House’s Rose Garden, said the U.S. will impose a baseline tariff of 10% on most U.S. imports and higher “reciprocal” rates on certain countries to address trade imbalances, but exempted some goods, including pharmaceuticals. The White House also said non-tariff barriers deprive U.S. manufacturers of reciprocal access to markets and called out India for imposing “uniquely burdensome and/or duplicative testing and certification requirements” in sectors including medical devices that make it difficult for U.S. companies to sell their products in the country. Meanwhile, providers have been bracing for the impact of tariffs.
Read the full article: Healthcare, Medtech Industries Brace for Tariffs //
Source: https://www.healthcaredive.com/news/Trump-tariffs-AdvaMed-healthcare-impact-exemption/744372